Zhang, Xin <br/><br/>
Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis.  [electronic resource] 

 -  Clinical neurology and neurosurgery  Sep 2010 
 - 641-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-6968 
<br/><br/><label>Standard No.: </label>10.1016/j.clineuro.2010.04.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Autoimmune Diseases--drug therapy<br/>Humans<br/>Immunity, Innate--drug effects<br/>Immunologic Factors--therapeutic use<br/>Interferon-beta--therapeutic use<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>T-Lymphocyte Subsets--drug effects<br/>Toll-Like Receptors--biosynthesis